APA (7th ed.) Citation

Yu, G., Zhou, H., Yao, W., Meng, L., & Lang, B. (2019). lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. Molecular therapy. Nucleic acids, 16, 257-271. https://doi.org/10.1016/j.omtn.2019.02.017

Chicago Style (17th ed.) Citation

Yu, Gan, Hui Zhou, Weimin Yao, Lirong Meng, and Bin Lang. "LncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing MiR-194-5p in Bladder Cancer." Molecular Therapy. Nucleic Acids 16 (2019): 257-271. https://doi.org/10.1016/j.omtn.2019.02.017.

MLA (9th ed.) Citation

Yu, Gan, et al. "LncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing MiR-194-5p in Bladder Cancer." Molecular Therapy. Nucleic Acids, vol. 16, 2019, pp. 257-271, https://doi.org/10.1016/j.omtn.2019.02.017.